KPV is an anti-inflammatory peptide that has the potential to reduce inflammation in intestinal diseases such as Crohn's and Ulcerative Colitis. By blocking the production and release of proinflammatory cytokines, KPV helps to curb the immune response that leads to inflammation. In studies, KPV has demonstrated efficacy in reducing inflammation and promoting the healing of the gut lining in patients with Inflammatory Bowel Diseases and ulcers. For example, in a study with mice with Ulcerative Colitis, KPV was found to lead to significant improvements in body weight, colon length, and symptoms. When combined with BPC, KPV has shown to be an even more potent anti-inflammatory agent.